Nautilus Biotechnology (NAUT) Common Equity (2020 - 2026)
Nautilus Biotechnology's Common Equity was $131.11 million in Q2 2026, down 27.6% from $181.09 million a year earlier and down 9.2% from the prior quarter.
Nautilus Biotechnology (NAUT) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Nautilus Biotechnology came in at $156.97 million, down 24.8% from FY2024.
- Common Equity has now declined for four consecutive years.
- In earlier years, Common Equity was $208.73 million in FY2024 (-21.3%), $265.35 million in FY2023 (-15.7%), $314.92 million in FY2022 (-13.4%) and $363.58 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q1 2021.
- Compared with a year earlier, Common Equity has declined for 17 straight quarters, with an average decline of 23.5% over the last eight quarters.
- Across the past five years, year-over-year decline in Common Equity ran from 13.2% in Q1 2023 to 27.6% in Q2 2026.
- Per Business Quant data, NAUT's Common Equity in the three quarters before Q2 2026 was $144.42 million (Q1 2026), $156.97 million (Q4 2025) and $169.14 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Nautilus Biotechnology | 141.22 Mn | 141.22 Mn | 175,000.00 | 131.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 131.11 Mn |
| Mar 31, 2026 | 144.42 Mn |
| Dec 31, 2025 | 156.97 Mn |
| Sep 30, 2025 | 169.14 Mn |
| Jun 30, 2025 | 181.09 Mn |
| Mar 31, 2025 | 194.44 Mn |
| Dec 31, 2024 | 208.73 Mn |
| Sep 30, 2024 | 223.43 Mn |
| Jun 30, 2024 | 235.28 Mn |
| Mar 31, 2024 | 249.49 Mn |
| Dec 31, 2023 | 265.35 Mn |
| Sep 30, 2023 | 277.27 Mn |
| Jun 30, 2023 | 289.67 Mn |
| Mar 31, 2023 | 303.72 Mn |
| Dec 31, 2022 | 314.92 Mn |
| Sep 30, 2022 | 325.34 Mn |
| Jun 30, 2022 | 337.56 Mn |
| Mar 31, 2022 | 349.71 Mn |
| Dec 31, 2021 | 363.58 Mn |
| Sep 30, 2021 | 377.85 Mn |
Nautilus Biotechnology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NAUT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NAUT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NAUT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();